newsfilter
← Latest News
GlobeNewswire·

Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs

NEWTON, Mass., July 18, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (NASDAQ:ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant u